IPA Submits Comments to CMS on CY 2026 Hospital Outpatient Proposed Rule

Infusion Providers Alliance2025-09-18T18:35:15+00:00

IPA Submits Comments to CMS on CY 2026 Hospital Outpatient Proposed RuleInfusion Providers Alliance2025-09-18T18:35:15+00:00

IPA Submits Comments to CMS on CY 2026 Physician Fee Schedule Proposed Rule

Infusion Providers Alliance2025-09-18T19:54:11+00:00

IPA Submits Comments to CMS on CY 2026 Physician Fee Schedule Proposed RuleInfusion Providers Alliance2025-09-18T19:54:11+00:00

IPA Joins Patient & Provider Organizations in Support of Bipartisan Bill to Protect Patient Access to Cancer and Complex Therapies

Infusion Providers Alliance2025-09-04T17:02:26+00:00

IPA Joins Patient & Provider Organizations in Support of Bipartisan Bill to Protect Patient Access to Cancer and Complex TherapiesInfusion Providers Alliance2025-09-04T17:02:26+00:00

Infusion Providers Alliance Applauds Reintroduction of “The Protecting Patient Access to Cancer and Complex Therapies Act”

Infusion Providers Alliance2025-07-09T19:59:13+00:00

Infusion Providers Alliance Applauds Reintroduction of “The Protecting Patient Access to Cancer and Complex Therapies Act”Infusion Providers Alliance2025-07-09T19:59:13+00:00

Infusion Providers Alliance Responds to Draft Guidance on Medicare Drug Price Negotiation Program

Infusion Providers Alliance2025-07-03T15:45:12+00:00

Infusion Providers Alliance Responds to Draft Guidance on Medicare Drug Price Negotiation ProgramInfusion Providers Alliance2025-07-03T15:45:12+00:00

Infusion Providers Alliance Sends Letter to Aetna Opposing Specialty Pharmacy Mandate

Infusion Providers Alliance2025-07-03T16:56:33+00:00

Infusion Providers Alliance Sends Letter to Aetna Opposing Specialty Pharmacy MandateInfusion Providers Alliance2025-07-03T16:56:33+00:00

IPA Joins 40+ Patient and Provider Groups in Letters to Congress and the FTC Detailing Dynamics Impacting Access to Biosimilars

Infusion Providers Alliance2025-06-04T13:48:31+00:00

IPA Joins 40+ Patient and Provider Groups in Letters to Congress and the FTC Detailing Dynamics Impacting Access to BiosimilarsInfusion Providers Alliance2025-06-04T13:48:31+00:00

Protecting Patient Access to Treatment in Part B

Infusion Providers Alliance2025-05-22T18:41:52+00:00

Protecting Patient Access to Treatment in Part BInfusion Providers Alliance2025-05-22T18:41:52+00:00

Commercial Payers & Patient Access Restrictions

Infusion Providers Alliance2025-06-04T13:41:54+00:00

Commercial Payers & Patient Access RestrictionsInfusion Providers Alliance2025-06-04T13:41:54+00:00

Underwater Biosimilars

Infusion Providers Alliance2025-05-22T18:47:06+00:00

Underwater BiosimilarsInfusion Providers Alliance2025-05-22T18:47:06+00:00